Ilka Wicke

Private Equity Investor at

Boehringer Ingelheim (Venture Capital)

Health Technology

Consumer Services

Finance

Profile

Ilka Wicke is an Investment Manager & Director at Boehringer Ingelheim (Venture Capital) since 2010.
She is also a Director at Pcovery ApS.
Previously, she worked as a Licensing Director at Boehringer Ingelheim GmbH, and as a Director at PROMETHERA Biosciences SA, Cardior Pharmaceuticals GmbH, and AgomAb Therapeutics NV.
Dr. Wicke holds a doctorate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main.

Ilka Wicke active positions

Companies	Position	Start
Boehringer Ingelheim (Venture Capital) Boehringer Ingelheim (Venture Capital) Investment ManagersFinance BIVF invests in companies located across the globe including the United States, Europe and China. The firm targets companies operating in groundbreaking innovation including cancer, regenerative medicine, auto-immunity indications, digital solutions and infectious disease. It participaotes in seed and early stage capital requirements. The firm acquires minority interest and makes follow-on investments. It also takes seat on the board of directors.	Private Equity Investor	2009-12-31

All active positions of Ilka Wicke

Former positions of Ilka Wicke

Companies	Position	End
PROMETHERA Biosciences SA PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases	Director/Board Member	2018-04-05
AGOMAB THERAPEUTICS NV	Director/Board Member	-
Cardior Pharmaceuticals GmbH Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Engages in discovery and development of therapies that target RNA as a means to prevent, repair & reverse diseases of the hearts	Director/Board Member	-
Boehringer Ingelheim GmbH Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Manufactures and wholesales animal health & pharmaceutical products	Corporate Officer/Principal	-
Pcovery ApS Pcovery ApS Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of invasive fungal infections	Director/Board Member	-

See the detail of Ilka Wicke's experience

Training of Ilka Wicke

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ilka Wicke's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
Boehringer Ingelheim GmbH Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Manufactures and wholesales animal health & pharmaceutical products	Health Technology
Johann Wolfgang Goethe-Universität Frankfurt am Main Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
PROMETHERA Biosciences SA PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases	Health Technology
Boehringer Ingelheim (Venture Capital) Boehringer Ingelheim (Venture Capital) Investment ManagersFinance BIVF invests in companies located across the globe including the United States, Europe and China. The firm targets companies operating in groundbreaking innovation including cancer, regenerative medicine, auto-immunity indications, digital solutions and infectious disease. It participaotes in seed and early stage capital requirements. The firm acquires minority interest and makes follow-on investments. It also takes seat on the board of directors.	Finance
Pcovery ApS Pcovery ApS Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of invasive fungal infections	Health Technology
Cardior Pharmaceuticals GmbH Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Engages in discovery and development of therapies that target RNA as a means to prevent, repair & reverse diseases of the hearts	Health Technology
AgomAb Therapeutics NV AgomAb Therapeutics NV BiotechnologyHealth Technology Develops molecular therapies for regeneration of damaged tissues	Health Technology

See company connections